Find policies, billing codes, payers, states, and providers
CPT 17313: Mohs Micrographic Surgery for Malignant Skin Lesion Excision
CPT code 17313 represents Mohs micrographic surgery, a precision surgical technique used to remove malignant skin lesions by excising tissue in stages with immediate microscopic examination to ensure clear margins. The procedure is clinically important for treating skin cancers where tissue preservation and margin control are critical, including basal cell carcinoma, squamous cell carcinoma, and certain melanomas. Nationwide, Mohs surgery is a key option in dermatologic oncology and reconstructive planning.
This publication examines payer coverage and coding context for CPT code 17313 across major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications, common billing companions, and related CPT entries for additional stages. The analysis summarizes typical sites of service and service type, and identifies relevant ICD-10 diagnoses commonly associated with Mohs procedures.
The report provides benchmarks and policy-focused summaries useful for billing compliance and revenue cycle staff, including comparisons to adjacent Mohs codes for additional stages or blocks. It also outlines clinical context to aid coding accuracy and claims submission. Data not available in the input are clearly noted where applicable.
Customize your policy alerts
Sign up for cpt 17313 policy alerts
Get alerted when payer policies referencing 17313 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 17313 describes Mohs micrographic surgery, a staged technique for excising malignant skin lesions layer by layer with immediate histopathologic examination to confirm negative margins. This procedure is a specialized surgical excision method focused on tissue conservation and complete tumor removal.
Service type: Surgical — Mohs micrographic technique
Typical site of service: Outpatient dermatologic surgical setting, often performed in an ambulatory surgery center or dermatology clinic with histopathology capability.
National Reimbursement Benchmarks
Nationally, Medicare's mean rate of $649.20 for CPT 17313 sits below BUCA's average commercial mean of $906.00, creating a gap of $256.80 between public and that commercial benchmark. This gap suggests material variation between Medicare and an aggregated commercial payor average, with BUCA positioned notably higher than Medicare on mean reimbursement for this code.
Dispersion measured as the interquartile range (P75 minus P25) varies across payers: Blue Cross Blue Shield shows a wide spread of $5,948.00 ($1,290.50 - $795.60), UnitedHealth Group has a wide spread of $5,525.00 ($1,087.70 - $535.20), while Aetna's spread is narrower at $3,706.00 ($720.00 - $349.40) and Cigna's is $5,426.00 ($972.60 - $430.00). BUCA's IQR is $5,022.00 ($1,134.60 - $642.40). The tightest IQR is Aetna and the widest is Blue Cross Blue Shield, indicating differences in rate consistency across carriers.